Free Access
Issue |
J Extra Corpor Technol
Volume 50, Number 1, March 2018
|
|
---|---|---|
Page(s) | 61 - 64 | |
DOI | https://doi.org/10.1051/ject/201850061 | |
Published online | 15 March 2018 |
- Staudacher DL, Bode C, Wengenmayer T Four situations in which ECMO might have a chance. Intensive Care Med. 2016;42:1305–6. [CrossRef] [PubMed] [Google Scholar]
- Schmidt M, Brechot N, Combes A Ten situations in which ECMO is unlikely to be successful. Intensive Care Med. 2016;42:750–2. [CrossRef] [PubMed] [Google Scholar]
- Wohlfarth P, Ullrich R, Staudinger T, et al. Extracorporeal membrane oxygenation in adult patients with hematologic malignancies and severe acute respiratory failure. Crit Care. 2014;18:R20. [CrossRef] [PubMed] [Google Scholar]
- Gow K, Wulkan M, Heiss K, et al. Extracorporeal membrane oxygenation for support of children after hematopoietic stem cell transplantation: The Extracorporeal Life Support Organization experience. J Pediatr Surg. 2006;41:662–7. [CrossRef] [PubMed] [Google Scholar]
- Di Nardo M, Locatelli F, Palmer K, et al. Extracorporeal membrane oxygenation in pediatric recipients of hematopoietic stem cell transplantation: An updated analysis of the Extracorporeal Life Support Organization experience. Intensive Care Med. 2014;40:754–6. [Google Scholar]
- Wolfson RK, Kahana MD, Nachman JB, et al. Extracorporeal membrane oxygenation after stem cell transplant: Clinical decision-making in the absence of evidence. Pediatr Crit Care Med. 2005;6:200–3. [CrossRef] [PubMed] [Google Scholar]
- Park J, Kreissman S, London W, et al. A phase III randomized clinical trial (RCT) of tandem myeloablative autologous stem cell transplant (ASCT) using peripheral blood stem cell (PBSC) as consolidation therapy for high–risk neuroblastoma (HR–NB): A Children’s Oncology Group (COG) study. J Clin Oncol. 2016;34:(Suppl; abstr LBA3). [Google Scholar]
- Fraser CJ, Weigel BJ, Perentesis JP, et al. Autologous stem cell transplantation for high-risk Ewing’s sarcoma and other pediatric solid tumors. Bone Marrow Transplant. 2006;37:175–81. [CrossRef] [PubMed] [Google Scholar]
- Yu AL, Gilman AL, Ozkaynak MF, et al. Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N Engl J Med. 2010;363:1324–34. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.